ARQ-171

N/A

Report date: 2022/10/14 20:00:43

NME

Base Information

Drug NameARQ-171

Drug Alias NameARQ-171

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTranscription factor E2F1 stimulants

TargetsTranscription factor E2F1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesArqule Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesArqule Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A